Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
334.0500 -3.15 (-0.93%)
NSE Jun 04, 2025 10:17 AM
Volume: 399.2K
 

logo
Biocon Ltd.
08 May 2025
334.05
-0.93%
pdf
Mar 2025 Dec 2024 Mar 2024 Change QoQ% Change YoY%
Total Revenue Qtr 4453.90 3856.20 3965.70 15.5% 12.3%
Operating Profit Qtr 1078.20 751.80 915.90 43.4% 17.7%
Net Profit Qtr 344.50 25.10 135.50 1272.5% 154.2%
Earning Per Share Adjusted latest Qtr 2.87 0.21 1.13 1266.7% 154.0%
* Consolidated data
Detailed Results
More from Biocon Ltd.
Recommended
Market opens flat, Zydus Life acquires two US-based biologics production facilities for $75 mn
Trendlyne Marketwatch | 04 Jun 2025, 10:01AM
Five stocks to buy from analysts this week - June 03, 2025
The Baseline | 03 Jun 2025, 04:42PM
A long drawn out R&D plan may be finally paying off for Biocon
| 20 Aug 2020